Peter Warendorf
Stock Analyst at Barclays
(3.80)
# 1,933
Out of 4,463 analysts
37
Total ratings
76.2%
Success rate
18%
Average return
Main Sectors:
Stocks Rated by Peter Warendorf
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Rated: Buy | $110 | $92.29 | +19.19% | 8 | Jul 1, 2026 | |
| PGNY Progyny | Rated: Buy | $23 → $27 | $29.45 | -8.32% | 8 | May 18, 2026 | |
| LFST LifeStance Health Group | Rated: Buy | $9 | $11.43 | -21.26% | 9 | May 12, 2026 | |
| TDOC Teladoc Health | Maintained: Hold | $7 | $9.10 | -23.08% | 7 | May 5, 2026 | |
| TALK Talkspace | Maintained: Hold | $5.5 → $5.25 | $5.20 | +0.96% | 5 | Mar 10, 2026 |
HealthEquity
Jul 1, 2026
Rated: Buy
Price Target: $110
Current: $92.29
Upside: +19.19%
Progyny
May 18, 2026
Rated: Buy
Price Target: $23 → $27
Current: $29.45
Upside: -8.32%
LifeStance Health Group
May 12, 2026
Rated: Buy
Price Target: $9
Current: $11.43
Upside: -21.26%
Teladoc Health
May 5, 2026
Maintained: Hold
Price Target: $7
Current: $9.10
Upside: -23.08%
Talkspace
Mar 10, 2026
Maintained: Hold
Price Target: $5.5 → $5.25
Current: $5.20
Upside: +0.96%